National Forum

Value & Access

Many of the 121.5 million Americans living with cardiovascular disease face barriers to getting the treatment that is right for them. The National Forum is engaging diverse stakeholders in a transformative, consensus-building initiative to overcome the barriers. Together, we are accelerating collaboration, breaking the stalemate and improving access to evidence-based care.

Improve Patient Access

The National Forum for Heart Disease & Stroke Prevention and 32 other organizations representing patients, healthcare providers, public health, payers and purchasers called on Congress and the White House to implement policies that will expand access to care options for patients nationwide, especially in underserved or otherwise vulnerable populations. This builds on a Joint Policy Statement issued by members and partners of the National Forum’s Value & Access Initiative, with recommendations that would enable people to obtain more healthcare services from pharmacists, often closer to where people live or work.

Watch the Roundtable on Community Pharmacists Impact on Cardiometabolic Health

Download the Slide Deck

Value & Access Initiative Reports & Resources

Check out resources developed through the Value & Access Initiative

Consensus Goal

Enhance health and well-being by supporting people’s access to evidence-based care that is appropriate for them by:

  • Identifying evidence-based strategies for determining appropriateness of care
  • Supporting the implementation of evidence-based care that aligns incentives for patients, providers, payers, other stakeholders

The Steering Committee will share research, facts, best practices and policies to advance the consensus goal through its Action Agenda.

Action Agenda

Understand Best Practices on Payer/Purchaser Coverage Decisions

Highlight a way for all stakeholders to communicate, share evidence, best practices & identify areas for improvement

Patient Engagement Strategies

Identify effective and scalable shared-decision making tools and models

Patient Adherence

Identify and endorse or highlight models, research, tools and resources

Shift Spend From Low- to High-Value Care

Identify & support effective leverage points already underway that meet stakeholder needs

Read More About Our:
Value & Access Resources
|
COVID-19 Resources

Value & Access Clearinghouse

Stakeholder Resources - Click on the Icons Below For Relevant Resources

Icon For Patients

Patients
Icon For PAYERS/ PURCHASERS

PAYERS/ PURCHASERS
Icon For Providers

Providers
Icon For Public Health

Public Health
Icon For PHARMA/ BIOTECH

PHARMA/ BIOTECH

Value & Access Partner Events

News & Op-Eds

FOR MORE INFORMATION, CONTACT JEN CHILDRESS

Steering Committee Members

The steering committee includes a broad range of experts representing public health, patients, providers, payers, and pharma/biotech.

Michael Cropp, MD, MBA

Title Steering Committee Chair

Positions held
  • President & CEO,
  • Independent Health

Penny Kris-Etherton, PhD, RD, FAHA, FNLA, FASN, CLS

Title Scientific Leader

Positions held
  • Evan Pugh University Professor of Nutritional Sciences, Department of Nutritional Sciences, The Pennsylvania State University

Patients

Andrea Baer

Positions held
  • Executive Director, Mended Hearts

Madeleine Konig, MPH

Positions held
  • Director, Value in Healthcare Initiative, American Heart Association (AHA)

Amy Friedrich-Karnik

Positions held
  • Director, Public Policy, WomenHeart

Sara Traigle van Geertruyden

Positions held
  • Executive Director, Partnership to Improve Patient Care

Payers & Purchasers

Jim Ballenger, MBA

Positions held
  • Principal, BallengeRx Consulting

Michael Cropp, MD, MBA

Positions held
  • President and Chief Executive Officer, Independent Health

Michael Thompson, FSA

Positions held
  • President and CEO, National Alliance of Healthcare Purchaser Coalitions

Providers

Stacy Manthos

Positions held
  • Executive Director, American Society for Preventive Cardiology (ASPC)

Benjamin M. Bluml, RPh

Positions held
  • Senior Vice President Research and Innovation, American Pharmacists Association (APhA) Foundation

Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

Positions held
  • Clinical Pharmacist Specialist, Grady Health System
  • National Lipid Association

Brian Hart, JD

Positions held
  • Executive Director, National Lipid Association

Sue Koob, MPA

Positions held
  • CEO, Preventive Cardiovascular Nurses Association (PCNA)

Karyn Lockshine, CAE

Positions held
  • Executive Director, American Association of Heart Failure Nurses

Cassandra McCullough, MBA

Positions held
  • CEO/Executive Director, Association of Black Cardiologists

J. Brendan Mullen

Positions held
  • Executive Vice President, American College of Cardiology

Public Health

A. Mark Fendrick, MD

Positions held
  • Director Center for Value-Based Insurance Design (V-BID), University of Michigan

Marcus Plescia, MD, MPH

Positions held
  • Chief Medical Officer , Association of State and Territorial Health Officials (ASTHO)

Fortunato “Fred” Senatore, MD, PhD, FACC 

Positions held
  • Medical Officer, Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration

Pharma/Biotech

Virginia Sweeter, CMP

Positions held
  • Director, Alliance Development & Education, National Pharmaceutical Council (NPC)

This initiative is made possible by support from the following:

Founding Sponsor

Sponsors

 

Novartis

 

 

In-Kind Contributors